Corticosteroid replacement in critical illness

Clinical Pulmonary Medicine

Volumn 10, Issue 5, 2003, Pages 278-288

  Coursin, Douglas B ^a   Liddy, Brian ^a   Wood, Kenneth E ^a  

^a Department of Anesthesiology ^*

Author keywords

Acute respiratory distress syndrome; Adrenal insufficiency; Critical illness; Glucocorticoid; Hypoadrenalism; Meningitis; Pneumocystis pneumonia; Replacement; Septic shock

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; HYPERTENSIVE FACTOR; METHYLPREDNISOLONE; PREDNISONE; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG USE; EVIDENCE BASED MEDICINE; FIBROBLAST; HORMONE SUBSTITUTION; HUMAN; MENINGITIS; META ANALYSIS; OUTCOMES RESEARCH; PNEUMOCYSTIS PNEUMONIA; RESPIRATORY DISTRESS; REVIEW; SEPTIC SHOCK; SPINAL CORD INJURY; STRESS; TYPHOID FEVER;

EID: 0141787096     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000087523.06377.36     Document Type: Review

References (72)

1. Coursin DB, Wood KE, Corticosteroid supplementation for adrenal insufficiency. JAMA. 2002;287:236-240.
2. Zaloga GP, Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin. 2001;17:25-41.
3. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002;122:1784-1796.
4. Shenke Y, Skatrud JB. Adrenal insufficiency in critically ill patients. Am J Resp Crit Care Med. 2001 163:1520-1523.
5. Lamberts SWJ, Bruining HA, deJong FH. Corticosteroid therapy in severe illness. N Engl J Med. 1997;337:1285-1292.
6. Warner ME. Witness to a miracle: the initial cortisone trial: an interview with Richard Freyberg, MD. Mayo Clinic Proc. 2001;76:529-532.
7. Hench PS, Slocumb CH, Polley HF, et al. Effect of cortisone and pituitary adrenocorticotrophic hormone (ACTH) on rheumatic diseases. JAMA. 1950;144:1327-1335.
8. Fraser CG, Preuss FS, Bigford WD. Adrenal atrophy and irreversible shock associated with cortisone therapy. JAMA. 1952;149:1542-1543.
9. Lewis L, Robinson RF, Yee J, et al. Fatal adrenal cortical insufficiency precipitated by surgery during prolonged continuous cortisone infusion. Ann Intern Med. 1953;39:116-125.
10. Salem M, Tanish RE, Bromberg J, et al. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann Surg. 1994;219:416-425.
11. Kehlet K, Binder C. Adrenocortical function and clinical course during and after surgery in unsupplemented glucocorticoid-treated patients. Br J Anesth. 1973;45:1043-1049.
12. Kehlet K, Binder C. Value of an ACTH test in assessing hypothalamicpituitary-adrenocortical function in glucocorticoid-treated patients. BMJ. 1973;2:147-149.
13. Kehlet H. Clinical Course and Hypothalamic-Pituitary-Adrenocortical Function in Glucocorticoid-Treated Surgical Patients. Copenhagen: FADL's Forlag; 1976.
14. Mohler JL, Flueck JA, McRoberts JW. Adrenal insufficiency following unilateral adrenal pseudocyst resection. J Urol. 1986;135:554-556.
15. Alford WC Jr, Meador CK, Mihalevich J, et al. Acute adrenal insufficiency following cardiac surgical procedures. J Thorac Cardiovasc Surg. 1979;78:489-493.
16. Mohler JL, Michel KA, Freedman AM, et al. The evaluation of postoperative function of the adrenal gland. Surg Gynecol Obstet. 1985;161: 551-556.
17. Nicholson G, Burrin JM, Hall GM. Peri-operative steroid supplementation. Anaesthesia. 1998;53:1091-1104.
18. Kehlet H. A rational approach to dosage and preparation of parenteral glucocorticoid substitution therapy during surgical procedures. Acta Anesth Scand. 1975;19:260-264.
19. Friedman RJ, Schiff CF, Bromberg JS. Use of supplemental steroids in patients having orthopedic operations. J Bone Joint Surg. 1995;77A: 1801-1806.
20. Gran L, Pahle JA. Rational substitution for steroid treated patients. Anaesthesia. 1978;33:59-61.
21. Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med. 1987;317:659-665.
22. Bone RC, Fisher CJ Jr, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317:653-658.
23. Bernard GR, Luce J, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317:1565-1570.
24. Hammerschmidt DE, White JG, Craddock PR, et al. Corticosteroids inhibit complement induced granulocyte aggregation: a possible mechanism for their efficacy in shock states. J Clin Invest. 1979;63:798-803.
25. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med. 1995;23:1294-1303.
26. Cronin L, Cook DJ, Cartlet J, et al. Corticosteroid for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med. 1995;23: 1430-1439.
27. Carlet J. From mega to more reasonable doses of corticosteroids: a decade to recreate hope. Crit Care Med. 1999;27:672-674.
28. Bollaert PE. Stress doses of glucocorticoids in catecholamine dependency: a new therapy for a new syndrome. Intensive Care Med. 2000; 26:3-5.
29. Annane D, Sebille V, Charpentier C, et al. Effects of treatment with low dose hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-871.
30. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. JAMA. 1998;280:159-165.
31. ARDS Network [Web site]. Late steroid rescue study. Available at: http://hedwig.mgh.harvard.edu/ardsnet/lasrs6200web.pdf.
32. Bracken MB. Methylprednisolone and acute spinal cord injury: an update of the randomized evidence. Spine. 2001;26:S47-S54.
33. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis: a meta-analysis of randomized clinical trials since 1988. JAMA. 1997;278:925-931.
34. Gagnon S, Boota AM, Fischl MA, et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990;323:1444-1450.
35. Meduri GU, Chrousos GP. Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way? Chest. 1998;114:355-360.
36. Meduri GU, Kanangat S. Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: time for a critical reappraisal. Crit Care Med. 1998;26:630-633.
37. Kenyon NJ, Albertson TE. Steroids and sepsis: time for another reevaluation. J Intensive Care Med. 2002;17:68-74.
38. Annane D. Corticosteroids for septic shock. Crit Care Med. 2001;29: S117-120.
39. Orth DN, Kovacs WJ. In: Wilson JD, Foster DW, Kronenberg HM, et al, eds. Williams Textbook of Endocrinology, 9th edition. Philadelphia: W. B. Saunders Co; 1998:517-665.
40. Streck WF, Lockwood DW. Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med. 1979;66:910-914.
41. Esteban NV, Loughlin T, Yergey AI, et al. Daily cortisol production in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab. 1991;72:39-45.
42. Drucker D, Shandling M. Variable adrenocortical function in acute medical illness. Crit Care Med. 1985;13:477-479.
43. Richards ML, Caplan RH, Wickus GG, et al. The rapid low dose (1 mcg) cosyntropin test in the immediate postoperative period: results in elderly subjects after major abdominal surgery. Surgery. 1999;125:431-440.
44. Oelkers W. Adrenal insufficiency. New Engl J Med. 1996;335:1206-1212.
45. Zipser RD, Davenport MW, Martin KL, et al. Hyperreninemic, hypoaldosteronism in the critically ill: a new entity. J Clin Endocrinol Metab. 1981;51:867-873.
46. Findling JW, Waters VO, Raff H. The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab. 1987;64:592-595.
47. La Rochelle G, La Rochelle AG, Ratner RE, et al. Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients receiving low-dose prednisone. Am J Med. 1993;95:258-264.
48. Annane D, Sebille V, Torche G, et al. A three level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000;283:1038-1045.
49. Oelkers W. The role of high- and low-dose corticotropin tests in the diagnosis of secondary adrenal insufficiency. Eur J Endocrinol. 1998; 139:567-570.
50. Udelsman R, Ramp J, Gallucci WT, et al. Adaptation during surgical stress: a re-evaluation of the role of glucocorticoids. J Clin Invest. 1986;44:1377-1381.
51. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998; 26:645-650.
52. Abraham E, Evans T. Corticosteroids and septic shock. JAMA. 2002; 288:886-887.
53. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
54. Schroeder S, Wichers M, Klingmuller D, et al. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med. 2001;29:310-316.
55. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind single center study. Crit Care Med. 1999;27:723-732.
56. Rivers EP, Gaspari M, Saad GA, et al. Adrenal insufficiency in high-risk surgical patients. Chest. 2001;119:889-896.
57. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
58. Molijn GJ, Spek JJ, van Uffelen JC, et al. Differential adaptation of glucocorticoid sensitivity to peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab. 1995;80: 1799-1803.
59. Udelsman R, Goldstein DS, Loriaux DL, et al. Catecholamine-glucocorticoid interactions during surgical stress. J Surg Res. 1987;43: 539-545.
60. Saito T, Takanashi M, Gallagher E, et al. Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic study. Intensive Care Med. 1995;21: 204-210.
61. Nieboer P, Van der Werf TS, Beentjes JAM, et al. Catecholamoine-dependency in a polytrauma patient: relative adrenal insufficiency? Intensive Care Med. 2000;26:125-127.
62. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322:1405-1411.
63. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: results of the third national acute spinal cord injury randomized controlled trial. JAMA. 1997;277: 1597-1604.
64. Fehlings MG. Recommendations regarding the use of methyprednisolone in acute spinal cord injury: making sense out of controversy. Spine. 2001;26:S56-57.
65. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg. 2000;93:1-7.
66. Thomas R, Le Tulzo Y, Bouget J, et al. Trial of dexamethasone treatment for severe bacterial meningitis in adults: Adult Meningitis Steroid Group. Intensive Care Med. 1999;25:475-480.
67. Coyle PK. Glucocorticoids in central nervous system bacterial infection. Arch Neurol. 1999;56:796-801.
68. De Gans J, Van De Beek D, Europear Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-1556.
69. Tunkel AR, Scheld WM. Corticosteroids for everyone with meningitis? N Engl J Med 2002;347:1613-1615.
70. MacFadden DK, Edelson JD, Hyland RH, et al. Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet. 1987;1: 1477-1479.
71. Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest. 1998;113:1215-1224.
72. Hoffman SL, Punjabi NH, Kumala S, et al. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med. 1984;310:82-88.